Literature DB >> 2375750

Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro.

D Chan1, S R Lamande, W G Cole, J F Bateman.   

Abstract

Procollagen biosynthesis and matrix deposition were studied in long-term human skin fibroblast cultures exposed to ascorbic acid. Ascorbic acid specifically stimulated types I and III collagen synthesis, reaching a maximum at day 2 and maintaining a specific high rate of production until day 10 of ascorbate exposure, after which collagen production declined. The increased level of collagen synthesis after different exposure times could also be achieved by only brief treatment (10 h) of parallel scorbutic (ascorbic-acid-deficient) cultures with ascorbic acid. This brief exposure did not result in increased collagen mRNA, thus demonstrating that the ascorbate-induced increase in collagen synthesis at all stages of ascorbic acid exposure was due to post-transcriptional mechanisms, most likely a rapid increase in type 1 collagen mRNA translational efficiency. This mechanism, rather than the transcriptional activation, was the primary response and is adequate to explain the ascorbate-induced increase in collagen synthesis. These data also demonstrate that the presence of a collagenous extracellular matrix was not involved in this collagen biosynthetic regulation. During long-term exposure (18 days) to ascorbic acid, a substantial cross-linked collagenous matrix formed, following an approximately sigmoidal time course. The most rapid matrix deposition occurred during the later days of exposure when the rate of collagen synthesis was decreasing, suggesting that the presence of a pre-existing matrix is important for further collagen accumulation. Procollagen was also efficiently processed to collagen during this phase, demonstrating that efficient procollagen processing is an important regulatory event in collagen matrix deposition.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2375750      PMCID: PMC1131548          DOI: 10.1042/bj2690175

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

Review 1.  Heritable diseases of collagen.

Authors:  D J Prockop; K I Kivirikko
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

2.  Cloning and characterization of five overlapping cDNAs specific for the human pro alpha 1(I) collagen chain.

Authors:  M L Chu; J C Myers; M P Bernard; J F Ding; F Ramirez
Journal:  Nucleic Acids Res       Date:  1982-10-11       Impact factor: 16.971

3.  Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Biochem J       Date:  1984-01-01       Impact factor: 3.857

4.  Ascorbate stimulation of PAT cells causes an increase in transcription rates and a decrease in degradation rates of procollagen mRNA.

Authors:  B L Lyons; R I Schwarz
Journal:  Nucleic Acids Res       Date:  1984-03-12       Impact factor: 16.971

5.  Ascorbate deficiency results in decreased collagen production: under-hydroxylation of proline leads to increased intracellular degradation.

Authors:  R A Berg; B Steinmann; S I Rennard; R G Crystal
Journal:  Arch Biochem Biophys       Date:  1983-10-15       Impact factor: 4.013

6.  Regulation of collagen synthesis by ascorbic acid. Ascorbic acid increases type I procollagen mRNA.

Authors:  S Tajima; S R Pinnell
Journal:  Biochem Biophys Res Commun       Date:  1982-05-31       Impact factor: 3.575

7.  Formation of collagen fibrils in vitro by cleavage of procollagen with procollagen proteinases.

Authors:  M Miyahara; F K Njieha; D J Prockop
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

8.  Specifically decreased collagen biosynthesis in scurvy dissociated from an effect on proline hydroxylation and correlated with body weight loss. In vitro studies in guinea pig calvarial bones.

Authors:  M Chojkier; R Spanheimer; B Peterkofsky
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

9.  Cloning a cDNA for the pro-alpha 2 chain of human type I collagen.

Authors:  J C Myers; M L Chu; S H Faro; W J Clark; D J Prockop; F Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  1981-06       Impact factor: 11.205

10.  Changes in the components of extracellular matrix and in growth properties of cultured aortic smooth muscle cells upon ascorbate feeding.

Authors:  E Schwartz; R S Bienkowski; B Coltoff-Schiller; S Goldfischer; O O Blumenfeld
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  29 in total

1.  Characterization of a new tissue-engineered human skin equivalent with hair.

Authors:  M Michel; N L'Heureux; R Pouliot; W Xu; F A Auger; L Germain
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-06       Impact factor: 2.416

2.  Enhancement of procollagen biosynthesis by p180 through augmented ribosome association on the endoplasmic reticulum in response to stimulated secretion.

Authors:  Tomonori Ueno; Keisuke Tanaka; Keiko Kaneko; Yuki Taga; Tetsutaro Sata; Shinkichi Irie; Shunji Hattori; Kiyoko Ogawa-Goto
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

3.  Collagen type I and III synthesis by Tenon's capsule fibroblasts in culture: individual patient characteristics and response to mitomycin C, 5-fluorouracil, and ascorbic acid.

Authors:  R L Gross
Journal:  Trans Am Ophthalmol Soc       Date:  1999

4.  Effect of dextran on synthesis, secretion and deposition of type III procollagen in cultured human fibroblasts.

Authors:  A Jukkola; J Risteli; L Risteli
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

5.  Identification of functional markers in a self-assembled skin substitute in vitro.

Authors:  Bisera Cvetkovska; Nazrul Islam; Francine Goulet; Lucie Germain
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

6.  Differentiation and mineralization in chick chondrocytes maintained in a high cell density culture: a model for endochondral ossification.

Authors:  C Farquharson; C C Whitehead
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-04       Impact factor: 2.416

7.  Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.

Authors:  A A Chiodo; D O Sillence; W G Cole; J F Bateman
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

8.  A type I collagen reporter gene construct for protein engineering studies. Functional equivalence of transfected reporter COL1A1 and endogenous gene products during biosynthesis and in vitro extracellular matrix accumulation.

Authors:  S R Lamandé; J F Bateman
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

9.  A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders.

Authors:  Robert C Gensure; Outi Mäkitie; Catherine Barclay; Catherine Chan; Steven R Depalma; Murat Bastepe; Hilal Abuzahra; Richard Couper; Stefan Mundlos; David Sillence; Leena Ala Kokko; Jonathan G Seidman; William G Cole; Harald Jüppner
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

10.  Collagen-cellulose composite thin films that mimic soft-tissue and allow stem-cell orientation.

Authors:  Terry W J Steele; Charlotte L Huang; Evelyne Nguyen; Udi Sarig; Saranya Kumar; Effendi Widjaja; Joachim S C Loo; Marcelle Machluf; Freddy Boey; Zlata Vukadinovic; Andreas Hilfiker; Subbu S Venkatraman
Journal:  J Mater Sci Mater Med       Date:  2013-05-14       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.